NURE | SCHH | NURE / SCHH | |
Gain YTD | -4.648 | 0.869 | -535% |
Net Assets | 37.1M | 7.9B | 0% |
Total Expense Ratio | 0.35 | 0.07 | 500% |
Turnover | 29.00 | 8.00 | 363% |
Yield | 3.67 | 3.15 | 116% |
Fund Existence | 9 years | 14 years | - |
NURE | SCHH | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago85% | 3 days ago88% |
Momentum ODDS (%) | 4 days ago73% | 3 days ago85% |
MACD ODDS (%) | 4 days ago79% | 3 days ago88% |
TrendWeek ODDS (%) | 4 days ago87% | 3 days ago83% |
TrendMonth ODDS (%) | 4 days ago86% | 3 days ago85% |
Advances ODDS (%) | 7 days ago84% | 6 days ago84% |
Declines ODDS (%) | 5 days ago85% | 4 days ago85% |
BollingerBands ODDS (%) | 7 days ago84% | 3 days ago84% |
Aroon ODDS (%) | 7 days ago80% | 3 days ago82% |
A.I.dvisor indicates that over the last year, NURE has been loosely correlated with SVC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NURE jumps, then SVC could also see price increases.
Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
---|---|---|---|---|
NURE | 100% | N/A | ||
SVC - NURE | 49% Loosely correlated | -0.82% | ||
AHT - NURE | 38% Loosely correlated | -2.60% | ||
NSA - NURE | -2% Poorly correlated | -0.90% | ||
AIV - NURE | -3% Poorly correlated | +0.81% | ||
EXR - NURE | -3% Poorly correlated | +0.14% | ||
More |
A.I.dvisor indicates that over the last year, SCHH has been closely correlated with EXR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCHH jumps, then EXR could also see price increases.
Ticker / NAME | Correlation To SCHH | 1D Price Change % | ||
---|---|---|---|---|
SCHH | 100% | +0.10% | ||
EXR - SCHH | 85% Closely correlated | +0.14% | ||
PLD - SCHH | 85% Closely correlated | +1.18% | ||
ARE - SCHH | 85% Closely correlated | -1.13% | ||
UDR - SCHH | 85% Closely correlated | -0.27% | ||
CUBE - SCHH | 84% Closely correlated | +0.20% | ||
More |